NYSE:CLB - Core Laboratories Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $52.37 -1.81 (-3.34 %) (As of 05/23/2019 10:49 AM ET)Previous Close$54.18Today's Range$52.01 - $52.7152-Week Range$53.49 - $129.43Volume5,838 shsAverage Volume670,472 shsMarket Capitalization$2.32 billionP/E Ratio25.51Dividend Yield4.01%Beta1.8 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands. Receive CLB News and Ratings via Email Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB Previous Symbol CUSIPN/A CIK1000229 Webhttp://www.corelab.com/ Phone31-20-420-3191Debt Debt-to-Equity Ratio1.92 Current Ratio1.84 Quick Ratio1.45Price-To-Earnings Trailing P/E Ratio25.51 Forward P/E Ratio26.32 P/E Growth2.13 Sales & Book Value Annual Sales$700.84 million Price / Sales3.31 Cash Flow$2.2219 per share Price / Cash Flow23.57 Book Value$4.22 per share Price / Book12.41Profitability EPS (Most Recent Fiscal Year)N/A Net Income$79.52 million Net Margins13.79% Return on Equity57.13% Return on Assets14.06%Miscellaneous Employees4,700 Outstanding Shares44,350,000Market Cap$2.32 billion Next Earnings Date7/24/2019 (Estimated) OptionableOptionable Core Laboratories (NYSE:CLB) Frequently Asked Questions What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories announced a quarterly dividend on Tuesday, April 16th. Investors of record on Friday, April 26th will be given a dividend of $0.55 per share on Tuesday, May 21st. This represents a $2.20 dividend on an annualized basis and a dividend yield of 4.21%. The ex-dividend date is Thursday, April 25th. View Core Laboratories' Dividend History. How were Core Laboratories' earnings last quarter? Core Laboratories (NYSE:CLB) issued its quarterly earnings data on Wednesday, April, 24th. The oil and gas company reported $0.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.43 by $0.01. The oil and gas company earned $169.19 million during the quarter, compared to analysts' expectations of $166.79 million. Core Laboratories had a net margin of 13.79% and a return on equity of 57.13%. Core Laboratories's revenue for the quarter was down .5% on a year-over-year basis. During the same quarter last year, the company earned $0.57 earnings per share. View Core Laboratories' Earnings History. When is Core Laboratories' next earnings date? Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, July 24th 2019. View Earnings Estimates for Core Laboratories. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories issued an update on its second quarter earnings guidance on Wednesday, April, 24th. The company provided earnings per share guidance of $0.47-0.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.49. The company issued revenue guidance of $172-175 million, compared to the consensus revenue estimate of $174.35 million.Core Laboratories also updated its Q2 2019 guidance to $0.47-0.50 EPS. What price target have analysts set for CLB? 15 analysts have issued 12-month target prices for Core Laboratories' shares. Their predictions range from $66.00 to $130.00. On average, they anticipate Core Laboratories' stock price to reach $87.40 in the next twelve months. This suggests a possible upside of 67.4% from the stock's current price. View Analyst Price Targets for Core Laboratories. What is the consensus analysts' recommendation for Core Laboratories? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories. Has Core Laboratories been receiving favorable news coverage? Media coverage about CLB stock has trended very negative on Thursday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Core Laboratories earned a news impact score of -3.8 on InfoTrie's scale. They also gave news headlines about the oil and gas company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of Core Laboratories' key competitors? Some companies that are related to Core Laboratories include Propetro (PUMP), Liberty Oilfield Services (LBRT), Oceaneering International (OII), RPC (RES), Franks International (FI), Select Energy Services (WTTR), SemGroup (SEMG), Helix Energy Solutions Group (HLX), C&J Energy Services (CJ), Keane Group (FRAC), National Energy Services Reunited (NESR), FTS International (FTSI), Mammoth Energy Services (TUSK), KLX Energy Services (KLXE) and US Well Services (USWS). What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Micron Technology (MU), Chipotle Mexican Grill (CMG), Starbucks (SBUX), Athabasca Oil (ATH), NIC (EGOV), Baidu (BIDU) and Netflix (NFLX). Who are Core Laboratories' key executives? Core Laboratories' management team includes the folowing people: Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.30%), WCM Investment Management LLC (7.02%), Kayne Anderson Rudnick Investment Management LLC (3.15%), JPMorgan Chase & Co. (2.71%), Select Equity Group L.P. (2.10%) and Neuberger Berman Group LLC (1.20%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories. Which major investors are selling Core Laboratories stock? CLB stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Renaissance Technologies LLC, SEI Investments Co, Northern Trust Corp, Comerica Bank, BlackRock Inc., Goldman Sachs Group Inc. and Howland Capital Management LLC. View Insider Buying and Selling for Core Laboratories. Which major investors are buying Core Laboratories stock? CLB stock was acquired by a variety of institutional investors in the last quarter, including Mairs & Power INC, Forsta AP Fonden, Lazard Asset Management LLC, Morgan Stanley, Royce & Associates LP, Wells Fargo & Company MN, Principal Financial Group Inc. and Scout Investments Inc.. View Insider Buying and Selling for Core Laboratories. How do I buy shares of Core Laboratories? Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $52.20. How big of a company is Core Laboratories? Core Laboratories has a market capitalization of $2.32 billion and generates $700.84 million in revenue each year. Core Laboratories employs 4,700 workers across the globe. What is Core Laboratories' official website? The official website for Core Laboratories is http://www.corelab.com/. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected] MarketBeat Community Rating for Core Laboratories (NYSE CLB)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 399 (Vote Outperform)Underperform Votes: 532 (Vote Underperform)Total Votes: 931MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: Understanding debt-to-equity ratio in fundamental analysis Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.